Skip to main content
. 2025 May 16;25:346. doi: 10.1186/s12877-025-06020-6

Table 3.

Comparison of sarcopenia assessments between T2DM patients with and without sarcopenia

Variables Total
(n = 329)
Sarcopenia
(n = 78)
Non- Sarcopenia
(n = 251)
P-value
Calf circumference (cm), mean ± SD 37.0 ± 4.0 33.0 ± 2.4 38.2 ± 3.6 < 0.001*
Waist circumference (cm), mean ± SD 94.5 ± 12.8 84.9 ± 11.0 97.5 ± 11.9 < 0.001*
Neck circumference (cm), mean ± SD 38.9 ± 4.2 36.3 ± 5.2 39.7 ± 3.5 < 0.001*
SARC-F, median (IQR) 1 (0, 3) 2 (1, 4) 1 (0, 2) 0.006*
 SARC-F ≥ 4, n (%) 55 (16.7) 20 (25.6) 35 (13.9) 0.016*
SARC-CalF, median (IQR) 2 (1, 5) 10 (2, 13) 1 (0, 3) < 0.001*
 SARC-CalF ≥ 11, n (%) 55 (16.7) 38 (48.7) 17 (6.8) < 0.001*
SARCF + EBM 2 (1, 10) 11 (3, 13) 2 (0, 4) < 0.001*
 SARCF + EBM ≥ 12, n (%) 59 (17.9) 28 (35.9) 31 (12.4) < 0.001*
Hand grip strength (kg), mean ± SD 22.5 ± 7.9 17.9 ± 7.0 24.0 ± 7.6 < 0.001*
 M < 28 kg; F < 18 kg, n (%) 174 (52.9) 63 (80.8) 111 (44.2) < 0.001*
5-times chair stand (sec), mean ± SD 15.9 ± 5.5 18.1 ± 5.8 15.2 ± 5.3 < 0.001*
 5-times chair stand ≥ 12 s, n (%) 242 (76.1) 67 (90.5) 175 (71.7) 0.001*
Gait speed (m/s), mean ± SD 0.85 ± 0.24 0.77 ± 0.25 0.87 ± 0.24 0.001*
 Gait speed < 1 m/s, n (%) 245 (75.2) 64 (84.2) 181 (72.4) 0.037*
Skeleton muscle mass index (kg/m2), mean ± SD 6.9 ± 1.2 5.6 ± 0.7 7.3 ± 1.0 < 0.001*
M < 7.0 kg/m2; F < 5.7 kg/m2, n (%) 89 (27.1) 78 (100.0) 11 (4.4) < 0.001*

Data were analysed with an independent t-test and Mann–Whitney U test

*Statistically significant at the 0.05 level (α = 0.05)